Latest Conference Articles

Your unrestricted view into eyecare conferences across the spectrum. Gain exclusive access to Ophthalmology Times Europe® expert-led conference coverage from major meetings throughout the year featuring articles, videos, and insights shared by prominent experts of the ophthalmic community

Review of findings presented at the American Academy of Ophthalmology annual meeting

Review of findings presented at the American Academy of Ophthalmology annual meeting

November 16th 2021, 9:46am

AAO

A brief overview of the plethora of findings presented at the 2021 American Academy of Ophthalmology meeting held November 12-15 in New Orleans, LA.

Drug delivery to retina via port delivery system is efficient for patients with wet AMD

Drug delivery to retina via port delivery system is efficient for patients with wet AMD

November 15th 2021, 5:15pm

AAO

In a poster presented at the American Academy of Ophthalmology 2021 annual meeting in New Orleans, Dr Mark Wieland noted that the port delivery system with ranibizumab provides drug delivery over an extended period.

Universal face masking reduces endophthalmitis incidence during anti-VEGF injections

Universal face masking reduces endophthalmitis incidence during anti-VEGF injections

November 14th 2021, 8:25pm

AAO

Dr Sunir J. Garg speaks on the influence of COVID-19 universal face masking on the risk of endophthalmitis following intravitreal anti-VEGF injections.

DMO: Study finds faricimab provides sustained retinal stability

DMO: Study finds faricimab provides sustained retinal stability

November 14th 2021, 7:45pm

AAO

During a presentation at the American Academy of Ophthalmology 2021 annual meeting in New Orleans, Dr Veeral Sheth presented research that found faricimab, a bispecific monoclonal antibody, provided sustained retinal stability in patients with diabetic macular oedema (DMO) compared with other retinal treatments.

Plasma metabolomic profiles could predict AMD progression

Plasma metabolomic profiles could predict AMD progression

November 14th 2021, 5:10pm

AAO

Speaking at the American Academy of Ophthalmology 2021 annual meeting in New Orleans, Dr Ines Lains explained that the mechanisms of AMD progression currently remain poorly understood and the tools to predict and halt progression are limited.

Presbyopia-correcting drops provide hope for frustrated patients

Presbyopia-correcting drops provide hope for frustrated patients

November 14th 2021, 3:11pm

AAO

Dr Cathleen McCabe describes how VUITY, the first and only FDA-approved eye drop to treat age-related blurry near vision, provides opportunities for patients looking for spectacle independence.

Central subfield thickness changes linked to worse visual outcomes in DMO

Central subfield thickness changes linked to worse visual outcomes in DMO

November 13th 2021, 8:00pm

AAO

Dr Ajay Kuriyan discusses his poster at AAO, "Fluctuations in central subfield thickness associated with worse visual outcomes in patients with diabetic macular oedema in clinical trial setting."

Though rare, ocular surface tumours often prove deadly

Though rare, ocular surface tumours often prove deadly

November 13th 2021, 5:10pm

AAO

In a presentation at the American Academy of Ophthalmology’s 2021 annual meeting in New Orleans, Nathan Hall pointed out that an epidemiologic analysis of malignant ocular surface tumours found significant differences in geographic prevalence rates in the United States.

Study reports that optic nerve pallor is prevalent in ZIKA virus patients

Study reports that optic nerve pallor is prevalent in ZIKA virus patients

November 13th 2021, 2:05pm

AAO

During a presentation at the American Academy of Ophthalmology 2021 annual meeting, Dr Denise Freitas reported that the ocular findings in infants with congenital Zika virus syndrome were similar among the affected infants and occurred frequently. The most prevalent of the findings was optic nerve pallor.

Study of bimatoprost implant reports IOP reduction for 2 years or more

Study of bimatoprost implant reports IOP reduction for 2 years or more

November 12th 2021, 8:35pm

AAO

Dr Felipe Medeiros in a presentation at the American Academy of Ophthalmology 2021 annual meeting in New Orleans, noted that a phase 3 clinical extension study of the bimatoprost implant found that patients’ IOP was lowered and stayed low with no additional treatment or changes in their visual fields.